financetom
Business
financetom
/
Business
/
Baozun Beats Revenue Estimates with Strong Q1 Growth, Shares Surge
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Baozun Beats Revenue Estimates with Strong Q1 Growth, Shares Surge
May 28, 2024 5:04 AM

Baozun Inc ( BZUN ) reported a fiscal first-quarter 2024 revenue growth of 4.9% year-on-year to 1.98 billion Chinese yuan ($274.2 million), beating the analyst consensus estimate of $269.6 million.

Adjusted loss per ADS was $0.03, compared to the analyst consensus estimate of $0.00. The stock price gained after the results.

The increase in total net revenues was mainly due to higher product sales revenue of Brand Management.

By the end of the quarter, approximately 42.8% of the BEC segment’s brand partners engaged with it for store operations in at least two channels.

Segments: Product sales revenue increased by 6.2% Y/Y to $98 million. 

Services revenue increased 4.1% Y/Y to $176.2 million.

The adjusted operating margin was negative 0.9% vs. negative 0.5% a year ago. 

The company held $408.1 million in cash and equivalents as of March-end.

Vincent Qiu, Chairman and Chief Executive Officer of Baozun ( BZUN ), commented, “E-Commerce has made progress in growing service revenue and introducing high-quality exclusive distribution models. Brand Management continues to advance in transforming Gap China, launching several China-for-China products and merchandising programs, which have shown positive market acceptance.”

Baozun ( BZUN ) stock lost 32% in value in the last 12 months. Investors can gain exposure to the stock via Dimensional ETF Trust Dimensional Emerging Markets Core Equity 2 ETF and Dimensional Emerging Core Equity Market ETF .

Price Action: BZUN shares traded higher by 5.17% at $2.85 premarket at the last check Tuesday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Innoviz Technologies. Auto Manufacturer Collaborate on Level 4 Autonomous Vehicle Technology
Innoviz Technologies. Auto Manufacturer Collaborate on Level 4 Autonomous Vehicle Technology
Jun 26, 2024
10:49 AM EDT, 06/26/2024 (MT Newswires) -- Innoviz Technologies ( INVZ ) said Wednesday it is collaborating with an undisclosed automotive original equipment manufacturer to advance Level 4 autonomous vehicle capabilities. Innoviz ( INVZ ) plans to add its new short-range light detection and ranging technology to the manufacturers' Level 4 autonomous driving platform. The company said the partnership will...
Paychex Expects Full-Year Earnings Growth Slowdown as Fourth-Quarter Results Beat Estimates
Paychex Expects Full-Year Earnings Growth Slowdown as Fourth-Quarter Results Beat Estimates
Jun 26, 2024
10:47 AM EDT, 06/26/2024 (MT Newswires) -- Paychex ( PAYX ) expects earnings growth to slow down year over year in fiscal 2025 even as it reported better-than-expected fourth-quarter results. The company projects per-share adjusted earnings to rise by 5% to 7% for the ongoing 12-month period, compared with the 11% gain it recorded in the fiscal year ended May...
Goldenstone Enters Merger Deal With Infintium Fuel Cell Systems
Goldenstone Enters Merger Deal With Infintium Fuel Cell Systems
Jun 26, 2024
10:50 AM EDT, 06/26/2024 (MT Newswires) -- Goldenstone Acquisition ( GDST ) , a blank check company, said Wednesday that it has entered into a business combination deal with Infintium Fuel Cell Systems. The transaction values Infintium at a pre-money enterprise value of $130 million. The deal will provide about $18 million in gross cash proceeds to Infintium at closing,...
Stratasys Says First Patient Enrolled in Study of 3D Printed Models for Orthopedic Tumor Removal
Stratasys Says First Patient Enrolled in Study of 3D Printed Models for Orthopedic Tumor Removal
Jun 26, 2024
10:52 AM EDT, 06/26/2024 (MT Newswires) -- Stratasys ( SSYS ) and Ricoh USA said Wednesday the first patient has been enrolled in a clinical study aimed at assessing the use of 3D printed models for orthopedic oncology. The study will evaluate the efficacy of patient-specific 3D printed anatomical models for preoperative planning and tumor excision, compared with the current...
Copyright 2023-2026 - www.financetom.com All Rights Reserved